Core Insights - Telix Pharmaceuticals Limited is hosting a webinar focused on innovations in PSMA-PET/CT imaging for prostate cancer, featuring key opinion leaders in the field [1][2]. Company Overview - Telix Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing therapeutic and diagnostic radiopharmaceuticals, with a focus on oncology and rare diseases [2]. - The company is headquartered in Melbourne, Australia, and operates internationally in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan [2]. Webinar Details - The webinar is scheduled for March 4, 2026, at 5:30 p.m. EST and will last approximately one hour [2]. - Registration for the event is available through a provided link [2]. Key Speakers - The webinar will feature notable speakers including Rodney Hicks, MD, and Paul Yonover, MD, who are recognized experts in the field of medicine and urology [8].
Investor Education Webinar